Citation only
via OpenAlex
Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study
Genliang Liu, Zhenwei Yu, Liyan Gao, Yuanchu Zheng, Tao Feng
Parkinsonism & Related Disorders · 2022 · ▲ 17 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.parkreldis.2022.09.011
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Liu, G., Yu, Z., Gao, L., Zheng, Y., & Feng, T. (2022). Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study. <em>Parkinsonism & Related Disorders</em>. https://doi.org/10.1016/j.parkreldis.2022.09.011
Vancouver
Liu G, Yu Z, Gao L, Zheng Y, Feng T. Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study. Parkinsonism & Related Disorders. 2022. doi:10.1016/j.parkreldis.2022.09.011.
BibTeX
@article{genliang2022Erythr,
title = {Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study},
author = {Genliang Liu and Zhenwei Yu and Liyan Gao and Yuanchu Zheng and Tao Feng},
journal = {Parkinsonism & Related Disorders},
year = {2022},
doi = {10.1016/j.parkreldis.2022.09.011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurobiology 2025
Preprint · CC-BY
A Mendelian randomization study on association of alpha-synuclein and GPNMB with Parkinson’s disease risk and progression
Progress in Lipid Research 2010
Citation only
Alpha-synuclein, lipids and Parkinson’s disease
Experimental Neurology 2017
Preprint · CC-BY
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Revue Neurologique 2020
Open access · OA